Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

Similar articles for PubMed (Select 24219729)

1.

Can anti-Müllerian hormone be predictive of spontaneous onset of pregnancy in women with unexplained infertility?

Casadei L, Manicuti C, Puca F, Madrigale A, Emidi E, Piccione E.

J Obstet Gynaecol. 2013 Nov;33(8):857-61. doi: 10.3109/01443615.2013.831050.

PMID:
24219729
2.

Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.

Lukaszuk K, Kunicki M, Liss J, Lukaszuk M, Jakiel G.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):173-7. doi: 10.1016/j.ejogrb.2013.01.013. Epub 2013 Feb 26.

PMID:
23485092
3.

Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.

Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.

Fertil Steril. 2009 Nov;92(5):1586-93. doi: 10.1016/j.fertnstert.2008.08.127. Epub 2008 Oct 18.

PMID:
18930213
4.

Chronological age vs biological age: an age-related normogram for antral follicle count, FSH and anti-Mullerian hormone.

Wiweko B, Prawesti DM, Hestiantoro A, Sumapraja K, Natadisastra M, Baziad A.

J Assist Reprod Genet. 2013 Dec;30(12):1563-7. doi: 10.1007/s10815-013-0083-1. Epub 2013 Aug 17.

5.

Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.

Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, Dede A.

Arch Gynecol Obstet. 2011 Jun;283(6):1415-21. doi: 10.1007/s00404-011-1889-7. Epub 2011 Mar 29.

PMID:
21562964
6.

Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.

Yilmaz N, Uygur D, Inal H, Gorkem U, Cicek N, Mollamahmutoglu L.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):257-60. doi: 10.1016/j.ejogrb.2013.04.003. Epub 2013 May 9.

PMID:
23664458
7.

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients.

Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R.

Fertil Steril. 2013 May;99(6):1644-53. doi: 10.1016/j.fertnstert.2012.12.048. Epub 2013 Feb 5.

8.

Impact of cancer therapies on ovarian reserve.

Gracia CR, Sammel MD, Freeman E, Prewitt M, Carlson C, Ray A, Vance A, Ginsberg JP.

Fertil Steril. 2012 Jan;97(1):134-40.e1. doi: 10.1016/j.fertnstert.2011.10.040. Epub 2011 Dec 2.

9.

Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility.

Gleicher N, Weghofer A, Barad DH.

Reprod Biol Endocrinol. 2010 Jun 17;8:64. doi: 10.1186/1477-7827-8-64.

10.

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.

Jayaprakasan K, Campbell B, Hopkisson J, Johnson I, Raine-Fenning N.

Fertil Steril. 2010 Feb;93(3):855-64. doi: 10.1016/j.fertnstert.2008.10.042. Epub 2008 Nov 30.

PMID:
19046583
11.

Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Ocal P, Sahmay S, Cetin M, Irez T, Guralp O, Cepni I.

J Assist Reprod Genet. 2011 Dec;28(12):1197-203. doi: 10.1007/s10815-011-9627-4. Epub 2011 Sep 1.

12.

Serum anti-müllerian hormone, follicle stimulating hormone and antral follicle count measurement cannot predict pregnancy rates in IVF/ICSI cycles.

Sahmay S, Demirayak G, Guralp O, Ocal P, Senturk LM, Oral E, Irez T.

J Assist Reprod Genet. 2012 Jul;29(7):589-95. doi: 10.1007/s10815-012-9754-6. Epub 2012 Apr 11.

13.

[Estimation of ovarian response using multiple predictors of ovarian reserve in women undergoing in vitro fertilization-embryo transfer].

He Y, Xia R, Chen X, Ye D, Tang Y, Li P, Niu J, Chen S.

Nan Fang Yi Ke Da Xue Xue Bao. 2013 Feb;33(2):216-20. Chinese.

14.

Antral follicle count determines poor ovarian response better than anti-Müllerian hormone but age is the only predictor for live birth in in vitro fertilization cycles.

Mutlu MF, Erdem M, Erdem A, Yildiz S, Mutlu I, Arisoy O, Oktem M.

J Assist Reprod Genet. 2013 Jun;30(5):657-65. doi: 10.1007/s10815-013-9975-3. Epub 2013 Mar 19.

15.

Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.

Sahmay S, Atakul N, Aydogan B, Aydin Y, Imamoglu M, Seyisoglu H.

Acta Obstet Gynecol Scand. 2013 Dec;92(12):1369-74. doi: 10.1111/aogs.12247. Epub 2013 Oct 15.

PMID:
23980726
16.
17.

Random anti-Müllerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels : anti-Müllerian hormone in poor responders in assisted reproductive treatment.

Celik H, Bıldırcın D, Güven D, Cetinkaya MB, Alper T, Batuoğlu AS.

J Assist Reprod Genet. 2012 Aug;29(8):797-802. doi: 10.1007/s10815-012-9794-y. Epub 2012 May 10.

18.
19.

Anti-Müllerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age.

Laven JS, Mulders AG, Visser JA, Themmen AP, De Jong FH, Fauser BC.

J Clin Endocrinol Metab. 2004 Jan;89(1):318-23.

PMID:
14715867
20.

Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.

Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E.

Reprod Biol. 2014 Sep;14(3):176-81. doi: 10.1016/j.repbio.2014.03.004. Epub 2014 Apr 19.

PMID:
25152514
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk